These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22343473)

  • 1. Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome.
    Li WW; Guo TZ; Liang DY; Sun Y; Kingery WS; Clark JD
    Anesthesiology; 2012 Apr; 116(4):882-95. PubMed ID: 22343473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance P spinal signaling induces glial activation and nociceptive sensitization after fracture.
    Li WW; Guo TZ; Shi X; Sun Y; Wei T; Clark DJ; Kingery WS
    Neuroscience; 2015 Dec; 310():73-90. PubMed ID: 26386297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute versus chronic phase mechanisms in a rat model of CRPS.
    Wei T; Guo TZ; Li WW; Kingery WS; Clark JD
    J Neuroinflammation; 2016 Jan; 13():14. PubMed ID: 26785976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome.
    Li WW; Guo TZ; Liang D; Shi X; Wei T; Kingery WS; Clark JD
    Pain; 2009 Dec; 147(1-3):277-86. PubMed ID: 19853379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitated spinal neuropeptide signaling and upregulated inflammatory mediator expression contribute to postfracture nociceptive sensitization.
    Shi X; Guo TZ; Wei T; Li WW; Clark DJ; Kingery WS
    Pain; 2015 Oct; 156(10):1852-1863. PubMed ID: 25932690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immobilization contributes to exaggerated neuropeptide signaling, inflammatory changes, and nociceptive sensitization after fracture in rats.
    Guo TZ; Wei T; Li WW; Li XQ; Clark JD; Kingery WS
    J Pain; 2014 Oct; 15(10):1033-45. PubMed ID: 25063543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cells: source of inflammation in complex regional pain syndrome?
    Schlereth T; Birklein F
    Anesthesiology; 2012 Apr; 116(4):756-7. PubMed ID: 22314295
    [No Abstract]   [Full Text] [Related]  

  • 8. Substance P signaling contributes to the vascular and nociceptive abnormalities observed in a tibial fracture rat model of complex regional pain syndrome type I.
    Guo TZ; Offley SC; Boyd EA; Jacobs CR; Kingery WS
    Pain; 2004 Mar; 108(1-2):95-107. PubMed ID: 15109512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II.
    Kingery WS; Davies MF; Clark JD
    Pain; 2003 Jul; 104(1-2):75-84. PubMed ID: 12855316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates Inhibit Pain, Bone Loss, and Inflammation in a Rat Tibia Fracture Model of Complex Regional Pain Syndrome.
    Wang L; Guo TZ; Hou S; Wei T; Li WW; Shi X; Clark JD; Kingery WS
    Anesth Analg; 2016 Oct; 123(4):1033-45. PubMed ID: 27636578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pinocembrin relieves hip fracture-induced pain by repressing spinal substance P signaling in aged rats.
    Xing B; Feng N; Zhang J; Li Y; Hou X; Wu H; Liu W; Han G
    J Neurophysiol; 2022 Feb; 127(2):397-404. PubMed ID: 34986062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-junctional facilitation of Substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I.
    Wei T; Li WW; Guo TZ; Zhao R; Wang L; Clark DJ; Oaklander AL; Schmelz M; Kingery WS
    Pain; 2009 Aug; 144(3):278-286. PubMed ID: 19464118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nonpeptide NK-1 receptor antagonists LY303870 and LY306740 block the responses of spinal dorsal horn neurons to substance P and to peripheral noxious stimuli.
    Radhakrishnan V; Iyengar S; Henry JL
    Neuroscience; 1998 Apr; 83(4):1251-60. PubMed ID: 9502263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide regulation of adaptive immunity in the tibia fracture model of complex regional pain syndrome.
    Li WW; Guo TZ; Shi X; Birklein F; Schlereth T; Kingery WS; Clark JD
    J Neuroinflammation; 2018 Apr; 15(1):105. PubMed ID: 29642930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision.
    Sahbaie P; Shi X; Guo TZ; Qiao Y; Yeomans DC; Kingery WS; Clark DJ
    Pain; 2009 Oct; 145(3):341-349. PubMed ID: 19660865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratinocyte expression of inflammatory mediators plays a crucial role in substance P-induced acute and chronic pain.
    Wei T; Guo TZ; Li WW; Hou S; Kingery WS; Clark JD
    J Neuroinflammation; 2012 Jul; 9():181. PubMed ID: 22824437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased bilateral expression of α1-adrenoceptors on peripheral nerves, blood vessels and keratinocytes does not account for pain or neuroinflammatory changes after distal tibia fracture in rats.
    Drummond ES; Dawson LF; Finch PM; Li W; Guo TZ; Kingery WS; Drummond PD
    Neuroscience; 2014 Dec; 281():99-109. PubMed ID: 25267387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LY303870, a centrally active neurokinin-1 antagonist with a long duration of action.
    Iyengar S; Hipskind PA; Gehlert DR; Schober D; Lobb KL; Nixon JA; Helton DR; Kallman MJ; Boucher S; Couture R; Li DL; Simmons RM
    J Pharmacol Exp Ther; 1997 Feb; 280(2):774-85. PubMed ID: 9023291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK-1 antagonist CP99994 inhibits stress-induced mast cell degranulation in rats.
    Erin N; Ersoy Y; Ercan F; Akici A; Oktay S
    Clin Exp Dermatol; 2004 Nov; 29(6):644-8. PubMed ID: 15550145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study on substance P in the regulation of degranulation of cultured murine mast cells].
    Cheng FL; Li QT; Zhao CQ; An YF; Qi XP
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Sep; 51(9):675-680. PubMed ID: 27666706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.